Dr. Everett Meyer, MD
Claim this profileStanford University
Area of expertise
Leukemia
Everett Meyer, MD has run 3 trials for Leukemia. Some of their research focus areas include:
Myelodysplastic Syndrome
Everett Meyer, MD has run 3 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
Stanford University
Stanford Health Care
Clinical Trials Everett Meyer, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting
1 award
Phase 1
Stem Cell Transplant
for Blood Cancers
Reduced intensity conditioning (RIC) has emerged and been increasingly adopted as a modality to allow preparative conditioning pre transplant to be tolerated by older adults or those patients that are otherwise unfit for myeloablative conditioning. In this study, we aim to use RIC followed by matched related/unrelated donor, 7/8 matched related/unrelated donor, or haploidentical donor peripheral blood stem cell transplantation. Standard strategies to control the alloreactivity following HCT utilize immunosuppressive or cytotoxic medications. In this study, we explore donor graft engineering to enrich for immmunoregulatory populations to facilitate post transplantation immune reconstitution while minimizing graft versus host disease (GVHD) with post-transplant immunosuppressive agents.
Recruiting
1 award
Phase 1
More about Everett Meyer, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Everett Meyer, MD has experience with
- Cyclophosphamide
- KYV-101
- Orca-T
- Fludarabine
- Donor Regulatory T Cells
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells
Breakdown of trials Everett Meyer, MD has run
Leukemia
Myelodysplastic Syndrome
Acute Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Everett Meyer, MD specialize in?
Everett Meyer, MD focuses on Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Leukemia has involved CD19 positive patients, or patients who are CD22 negative.
Is Everett Meyer, MD currently recruiting for clinical trials?
Yes, Everett Meyer, MD is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Everett Meyer, MD has studied deeply?
Yes, Everett Meyer, MD has studied treatments such as Cyclophosphamide, KYV-101, Orca-T.
What is the best way to schedule an appointment with Everett Meyer, MD?
Apply for one of the trials that Everett Meyer, MD is conducting.
What is the office address of Everett Meyer, MD?
The office of Everett Meyer, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.